A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.
Several professionals said the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.
Service Response and Material Removal
According to the social media company, the platform has taken down violative material and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
Within minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.
Item Details and Costs
Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has already seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly serious health risks”.
